Two different functions for CD44 proteins in human myelopoiesis

Journal of Clinical Investigation

Volumn 102, Issue 5, 1998, Pages 1024-1034

  Moll, J ^a   Khaldoyanidi, S ^a   Sleeman, J P ^a   Achtnich, M ^b   Preuss, I ^a   Ponta, H ^a   Herrlich, P ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

CD44; Chondroitin sulphate A; Hyaluronate; Long term bone marrow culture; Myelopoiesis

Indexed keywords

HERMES ANTIGEN;

ANTIGEN BINDING; ARTICLE; BONE MARROW CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MYELOPOIESIS; PRIORITY JOURNAL; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032167434     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2494     Document Type: Article

References (65)

1. Lesley, J., R. Hyman, and P.W. Kincade. 1993. CD44 and its interaction with the extracellular matrix. Adv. Immunol. 54:271-335.
2. Herrlich, P., M. Zöller, S.T. Pals, and H. Ponta. 1993. CD44 splice variants: metastases meet lymphocytes. Immunol. Today. 14:395-399.
3. Rudy, W., M. Hofmann, R. Schwartz-Alhiez, M. Zöller, K.H. Heider, H. Ponta, and P. Herrlich. 1993. The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res. 53:1262-1268.
4. Jackson, D.G., J.I. Bell, R. Dickinson, J. Timans, J. Shields, and N. Whittle. 1995. Proteoglycan forms on the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J. Cell Biol. 128:673-685.
5. Aruffo, A., I. Stamenkovic, M. Melnick, C.B. Underhill, and B. Seed. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1303-1313.
6. Miyake, K., C.B. Underhill, J. Lesley, and P.W. Kincade. 1990. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Meet. 172:69-75.
7. Weber, G.F., S. Ashkar, M.J. Glimcher, and H. Cantor. 1996. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science. 271:509-512.
8. Bennett, K.L., D.G. Jackson, J.C. Simon, E. Tanczos, R. Peach, B. Modrell, I. Stamenkovic, G. Plowman, and A. Aruffo. 1995. CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol. 128:687-698.
9. Arch, R., K. Wirth, M. Hofmann, P. Ponta, S. Matzku, P. Herrlich, and M. Zöller. 1992. Participation in normal immune responses of a splice variant of CD44 that encodes a metastasis-inducing domain. Science. 257:682-685.
10. Koopman, G., K.H. Heider, E. Horst, G.R. Adolf, F. van den Berg, H. Ponta, P. Herrlich, and S.T. Pals. 1993. Activated human lymphocytes and aggressive non-Hodgkin lymphomas express a homologue of the rat metastasis-associated variant of CD44. J. Exp. Med. 177:897-904.
11. Screaton, G.R., J.F. Caceres, A. Mayeda, M.V. Bell, M. Plebanski, D.G. Jackson, J.I. Bell, and A.R. Krainer. 1995. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J. 14:4336-4349.
12. Moll, J., A. Schmidt, H. van der Putten, R. Plug, H. Ponta, P. Herrlich, and M. Zöller. 1996. Accelerated immune response in transgenic mice expressing rat CD44v4-v7 on T cells. J. lmmunol. 156:2085-2094.
13. Zöller, M., A. Schmidt, A. Wenzel, and J. Moll. 1997. Constitutive expression of a CD44 variant isoform on T cells facilitates regaining of immuno-competence in allogeneic bone marrow transplantation. Blood. 90:873-885.
14. Gallagher, J.T., E. Spooncer, and T.M. Dexter. 1983. Role of the extra-cellular matrix in hemopoiesis. I. Synthesis of glycosaminoglycans by mouse bone marrow cell cultures. J. Cell. Sci. 63:155-161.
15. Wight, T.N., M.G. Kinsella, A. Keating, and J.W. Singer. 1986. Proteoglycans in human long-term bone marrow cultures: biochemical and ultra-structural analysis. Blood. 67:1333-1343.
16. Siczkowski, M., A.S. Amos, and M.Y. Gordon. 1993. Hyaluronic acid regulates the function and distribution of sulfated glycosaminoglycans in bone marrow stromal cultures. J. Exp. Hematol. 21:126-130.
17. Legras, S., J.P. Levesque, R. Charrad, K. Morimoto, C. Le Bousse, D. Clay, C. Jasmin, and F. Smadja-Joffe. 1997. CD44-mediated adhesiveness of human hematopoietic progenitors to hyaluronan is modulated by cytokines. Blood. 89:1905-1914.
18. Kitamura, T., T. Tange, T. Terasawa, T. Chiba, T. Kuwaki, K. Miyagawa, Y.F. Piao, K. Miyazono, A. Urabe, and F. Takaku. 1989. Establishment and characterization of a unique human line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol. 140:323-334.
19. Itoh, K., H. Tezuka, H. Sakoda, M. Konno, K. Nagata, T. Uchiyama, H. Uchino, and K.J. Mori. 1989. Reproducible establishment of hematopoietic supportive stromal cell lines from murine bone marrow. Exp. Hematol. 17:145-153.
20. Collins, S.J. 1987. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood. 70:1233-1244.
21. Zuckermann, F.A., R.M. Binns, R. Husmann, H. Yang, M.M. Carr, Y.B. Kim, W.C. Davis, M. Mistfeldt, and J.K. Lunney. 1993. Analysis of monoclonal antibodies reactive with porcine CD44 and CD45. Vet. Immunol. Immunopathol 43:293-305.
22. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY.
23. van Weering, D.H.J., P.D. Baas, and J.L. Bos. 1993. A PCR-based method for the analysis of human CD44 splice products. PCR Meth. Appl. 3: 100-106.
24. Jalkanen, S.T., R.F. Bargatze, L.R. Herron, and E.C. Butcher. 1986. A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur. J. Immunol. 16:1195-1202.
25. Heider, K.H., M. Hofmann, E. Horst, F. van den Berg, H. Ponta, P Herrlich, and S.T. Pals. 1993. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J. Cell Biol. 120:227-233.
26. de Belder, A.N., and K.O. Wik. 1975. Preparation and properties of fluorescein-labeled hyaluronate. Carbohydr. Res. 44:251-257.
27. Lee, T.H., H.G. Wisniewski, and J. Vilcek. 1992. A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44. J. Cell Biol. 116:545-557.
28. Neu, S., A. Geiselhart, M. Sproll, D. Hahn, S. Kuci, D. Niethammer, and R. Handgretinger. 1997. Expression of CD44 isoforms by highly enriched CD34-positive cells in cord blood, bone marrow and leukaphereses. Bone Marrow Transplant. 20:593-598.
29. Fischkoff, S., A. Pollak, A. Gleich, J. Testa, S. Misawa, and T. Reher. 1984. Eosinophilic differentiation of the human promyelocytic leukemia cell line HL-60, J. Exp. Med. 160:179-196.
30. Kansas, O.S., M.J. Muirhead, and M.O. Daily. 1990. Expression of the CD11/CD18 leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation. Blood. 76:2483-2492.
31. Tettero, P.A.T., F. Massaro, A. Mulder, R. Schrender-von Gelder, and A.E.G. van den Borne. 1984. Megakaryoblastic differentiation of proerythroblastic K562 cell line cells. Leuk. Res. 8:197-206.
32. Murate, T., S. Saga, T. Hotta, H. Asano, T. Ito, K. Kato, K. Tsushita, T. Kinoshita, A. Ichikawa, S. Yoshida, et al. 1993. The close relationship between DNA replication and the selection of differentiation lineages of human erythroleukemia cell lines K562, HEL, and TF1 into erythroid or megakaryocytic lineages. Exp. Cell. Res. 208:35-43.
33. Screaton, G.R., M.V. Bell, D.G. Jackson, F.B. Cornelis, U. Gerth, and J.I. Bell. 1992. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA. 89:12160-12164.
34. Dougherty, G.J., P.M. Landorp, D.L. Cooper, and R.K. Humphries. 1991. Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 "homing" receptor expressed by hemopoietic cells. J. Exp. Med. 174:1-5.
35. Peach, R.J., D. Hollenbaugh, I. Stamenkovic, and A. Aruffo. 1993. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol. 122:257-264.
36. Morimoto, K., E. Robin, M.C LeBousse-Kerdiles, Y. Ly, D. Clay, C. Jasmin, and F. Smadja-Joffe. 1994. CD44 mediates hyaluronate binding by human myeloid KG1A and KG1 cells. Blood. 83:657-662.
37. Moll, J., J.P. Sleeman, K. Kondo, A. Hekele, R. Plug, L. Sherman, A. Schmidt, M. Zöller, E. Horst, H. Ponta, et al. 1994. Analysis of molecular functions of the tumor metastasis promoting surface molecule CD44v4-v7 using transgenic mice. In Molecular and Cellular Basis for Cell to Cell Interaction: Its Significance in Cancer. S. Hirohashi, H.L. Moses, E. Ruoslahti, T. Sugimura, M. Takeichi, and M. Terada, editors. Princeton Scientific Publ. Co., Princeton, NJ. 142-151.
38. Sherman, L., J.P. Sleeman, P. Herrlich, and H. Ponta. 1994. Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr. Opin. Cell. Biol. 6:726-733.
39. Hardwick, C., K. Hoare, R. Owens, H.P. Hohn, M. Hook, D. Moore, V. Cripps, L. Austen, D.M. Nance, and E.A. Turley. 1992. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motilily. J. Cell Biol. 117: 1343-1350.
40. McCourt, P.A., B. Ek, N. Forsberg, and S. Gustafson. 1994. Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J. Biol. Chem. 269:30081-30084.
41. Sleeman, J.P., S. Arming, J. Moll, H. Hekele, W. Rudy, L. Sherman, G. Kreil, H. Ponta, and P. Herrlich. 1996. Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells. Cancer Res. 56: 3134-3141.
42. Sleeman, J.P., K. Kondo, J. Moll, H. Ponta, and P. Herrlich. Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44. J. Biol. Chem. 272:31837-31844.
43. Uff, C.R., S.J. Neame, and C.M. Isacke. 1995. Hyaluronan binding by CD44 is regulated by a phosphorylation-dependent mechanism. Eur. J. Immunol. 25:1883-1887.
44. Puré, E., R.L. Camp, D. Perrit, R.A. Panettieri, A.L. Lazaar, and S. Nayak. 1995. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmatic domain. J. Exp. Med. 181:55-62.
45. Sugimoto, K., Y. Tsurumaki, H. Hoshi, S. Kadowaki, M.C. LeBousseKerdiles, F. Smadja-Joffe, and K.J. Mori. 1994. Effects of anti-CD44 monoclonal antibody on adhesion of erythroid leukemic cells (ELM-1-1) to hemopoietic supportive cells (MS-5): CD44, but not hyaluronate-mediated, cell-cell adhesion. Exp. Hematol. 22:488-494.
46. Hudson, D.L., J. Sleeman, and F.M. Watt. 1995. CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in cellular adhesion. J. Cell. Sci. 108:1959-1970.
47. Miyake, K., K.L. Medina, S.I. Hayashi, S. Ono, T. Hamaoka, and P.W. Kincade. 1990. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J. Exp. Med. 171:477-488.
48. Miyake K., C.B. Underhill, J. Lesley, and P.W. Kincade. 1990. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med. 172:69-75.
49. Schmits, R., J. Filmus, N. Gerwin, G. Senaldi, F. Kiefer, T. Kundig, A. Wakeham, A. Shahinian, C. Catzavelos, J. Rak, et al. 1997. CD44 regulates hemopoietic progenitor disiribution, granuloma formation, and tumorigenicity. Blood. 90:2217-2233.
50. Rossbach, H.C., L. Krizanac-Bengez, E.B. Santos, T.A. Gooley, and B.M. Sandmaier, 1996. An antibody to CD44 enhances hematopoiesis in long-term marrow cultures. Exp. Hematol. 24:221-227.
51. Ghaftari, S., G.J. Dougherty, A.C. Eaves, and C.J. Eaves. 1997. Diverse effects of anti-44 antibodies on the stromal cell-mediated support of normal but not leukaemic (CML) haemopoiesis in vitro. Br. J. Haematol. 97:22-28.
52. Ghaffari, S., G.J. Dougherty, P.M. Lansdorp, A.C. Eaves, and C.J. Eaves. 1995. Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia. Blood. 15:2976-2985.
53. Sleeman J., W. Rudy, M. Hofmann, J. Moll, P. Herrlich, and H. Ponta. 1996. Regulated clustering of variant CD44 proteins increase their hyaluronate binding capacity. J. Cell Biol. 135:1139-1150.
54. Lesley, J., N. English, A. Perschl, J. Gregoroff, and R. Hyman. 1995. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med. 182:431-437.
55. Katoh, S., Z. Zheng, K. Oritani, T. Shimozato, and P.W. Kincade. 1995. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med. 182:419-429.
56. Lugasi, H., S. Hajos, J.R. Murphy, T.B. Strom, J. Nichols, C. Penarroja, and D. Naor. 1990. Murine spontaneous T-cell leukemia constitutively expressing IL-2 receptor: a model for human T-cell malignancies expressing IL-2 receptor. Int. J. Cancer. 45:163-167.
57. Gordon, M.Y., G.P. Riley, S.M. Watt, and M.F. Greaves. 1987. Compartmentalization of a hematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature. 326:403-405.
58. Suzum, S., T. Inaba, N. Yanai, T. Kawashima, N. Yamada, T. Oka, R. Machinami, T. Ohtsuki, F. Kimura, and S. Kondo. 1994. Proteoglycan form of macrophage colony-stimulating factor binds low density lipoprotein. J. Clin Invest. 94:1637-1641.
59. Toyama-Sorimachi, N., and M. Miyasaka. 1994. A novel ligand for CD44 is sulfated proteoglycan. Int. Immunol. 6:655-660.
60. Toyama-Sorimachi, N., H. Sorimachi, Y. Tobita, F. Kitamura, H. Yagita, K. Suzuki, and M. Miyasaka. 1995. A novel ligand for CD44 is serglycin, a hematopnietic cell lineage-specific proteoelycan. J. Biol. Chem. 270:7437-7444.
61. Naujokas, M., M. Morin, M.S. Anderson, M. Peterson, and J. Miller. 1993. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell. 74:257-268.
62. Droll, A., S.T. Dougherty, R.K. Chiu, J.F Dirks, W.H. McBride, D.L. Cooper, and G.J. Dougherty. 1995. Adhesive interactions between alternatively spliced CD44 isoforms. J. Biol. Chem. 270:11567-11571.
63. Peter, A., G. McCourt, and S. Gustafson. 1997. On the adsorption of hyaluronan and ICAM-1 to modified Hydrophobic resins. Int. J. Biochem. Cell. Biol. 29:1179-1183.
64. Assmann, V., J.F. Marshall, C. Fieber, M. Hofmann, and I.R. Hart. 1998. The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells. J. Cell. Sci. 111:1685-1694.
65. Hofmann, M., C. Fieber, V. Assmann, M. Gottlicher, J. Sleeman, R. Plug, N. Howells, O. von Stein, H. Ponta, and P. Herrlich. 1998. Identification of IHABP, a 95 KDa intracellular hyaluronate binding protein. J. Cell. Sci. 111: 1673-1684.